ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,981,000 | -14.0% | 1,782,567 | -0.3% | 0.00% | -33.3% |
| Q1 2019 | $24,409,000 | +47.0% | 1,788,219 | +10.4% | 0.00% | +50.0% |
| Q4 2018 | $16,606,000 | -52.4% | 1,620,057 | -22.6% | 0.00% | -50.0% |
| Q3 2018 | $34,867,000 | -8.1% | 2,094,091 | -12.8% | 0.00% | 0.0% |
| Q2 2018 | $37,945,000 | +51.4% | 2,401,565 | +21.7% | 0.00% | +33.3% |
| Q1 2018 | $25,069,000 | +24.9% | 1,973,965 | +12.6% | 0.00% | +50.0% |
| Q4 2017 | $20,075,000 | -61.9% | 1,753,239 | -59.3% | 0.00% | -66.7% |
| Q3 2017 | $52,740,000 | -18.2% | 4,305,307 | -23.5% | 0.01% | -25.0% |
| Q2 2017 | $64,461,000 | -58.6% | 5,629,800 | -24.7% | 0.01% | -60.0% |
| Q1 2017 | $155,521,000 | -0.4% | 7,476,984 | -0.4% | 0.02% | -4.8% |
| Q4 2016 | $156,214,000 | -36.7% | 7,510,264 | -0.2% | 0.02% | -36.4% |
| Q3 2016 | $246,684,000 | +33.4% | 7,527,732 | +1.7% | 0.03% | +32.0% |
| Q2 2016 | $184,881,000 | +15.0% | 7,404,134 | +12.8% | 0.02% | +13.6% |
| Q1 2016 | $160,742,000 | -24.5% | 6,563,585 | +1.9% | 0.02% | -24.1% |
| Q4 2015 | $212,849,000 | +7.7% | 6,444,124 | +6.8% | 0.03% | +3.6% |
| Q3 2015 | $197,701,000 | -41.4% | 6,034,846 | -5.2% | 0.03% | -34.9% |
| Q2 2015 | $337,158,000 | +1421.2% | 6,365,072 | +728.8% | 0.04% | +1333.3% |
| Q1 2015 | $22,164,000 | +107.1% | 767,978 | +108.7% | 0.00% | +200.0% |
| Q4 2014 | $10,704,000 | +10.0% | 367,978 | -52.1% | 0.00% | 0.0% |
| Q3 2014 | $9,733,000 | -36.8% | 767,604 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $15,406,000 | – | 767,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |